Genome-scale CRISPR-Cas9 knockout screening in human cells

Shalem, Ophir, Sanjana, Neville E., Hartenian, Ella, Shi, Xi, Scott, David A., Mikkelsen, Tarjei S., Heckl, Dirk, Ebert, Benjamin L. +3 more·2014·Science

Cited by (1,041)

Items 601–700 of 1,041

  1. Defining an olfactory receptor function in airway smooth muscle cells
    William H. Aisenberg, Jessie Huang, Wanqu Zhu, Premraj Rajkumar, Randy Cruz, Lakshmi Santhanam, Niranjana Natarajan, Hwan Mee Yong, Breann De Santiago, Jung Jin Oh et al. · 2016 · Scientific Reports
  2. Cancer CRISPR Screens In Vivo
    Ryan Dz-Wei Chow, Sidi Chen · 2018 · Trends in cancer
  3. Zika Virus Non-structural Protein 4A Blocks the RLR-MAVS Signaling
    Jinzhu Ma, Harshada Ketkar, Tingting Geng, Emily Lo, Leilei Wang, Juemin Xi, Qiangming Sun, Zhanbo Zhu, Yudong Cui, Long Yang et al. · 2018 · Frontiers in Microbiology
  4. Delivering Cas9/sgRNA ribonucleoprotein (RNP) by lentiviral capsid-based bionanoparticles for efficient ‘hit-and-run’ genome editing
    Pin Lyu, Parisa Javidi-Parsijani, Anthony Atala, Baisong Lu · 2019 · Nucleic Acids Research
  5. A new age in functional genomics using CRISPR/Cas9 in arrayed library screening
    Alexander Agrotis, Robin Ketteler · 2015 · Frontiers in Genetics
  6. The Hyaluronidase, TMEM2, Promotes ER Homeostasis and Longevity Independent of the UPRER
    Robert T. Schinzel, Ryo Higuchi‐Sanabria, Ophir Shalem, Erica A. Moehle, Brant Michael Webster, Larry K. Joe, Raz Bar‐Ziv, Phillip Andrew Frankino, Jenni Durieux, Corinne L. Pender et al. · 2019 · Cell
  7. Frequent Loss of IRF2 in Cancers Leads to Immune Evasion through Decreased MHC Class I Antigen Presentation and Increased PD-L1 Expression
    Kriegsman, Barry A, Vangala, Pranitha, Chen, Benjamin J, Meraner, Paul, Brass, Abraham L, Garber, Manuel, Rock, Kenneth L · 2019 · The Journal of Immunology
  8. edgeR: a versatile tool for the analysis of shRNA-seq and CRISPR-Cas9 genetic screens
    Zhiyin Dai, Julie M. Sheridan, Linden J. Gearing, Darcy Moore, Shian Su, Sam Wormald, Stephen Wilcox, Liam O’Connor, Ross A. Dickins, Marnie E. Blewitt et al. · 2014 · F1000Research
  9. CRISPR/Cas9-mediated genome engineering of CHO cell factories: application and perspectives
    Lee, Jae Seong, Grav, Lise Marie, Lewis, Nathan E., Faustrup Kildegaard, Helene · 2015 · Biotechnology Journal
  10. Genome-Wide CRISPR Screen for Essential Cell Growth Mediators in Mutant KRAS Colorectal Cancers
    Edwin H. Yau, Indrasena Reddy Kummetha, Gianluigi Lichinchi, Rachel Tang, Yunlin Zhang, Tariq M. Rana · 2017 · Cancer Research
  11. Ectopic expression of RAD52 and dn53BP1 improves homology-directed repair during CRISPR–Cas9 genome editing
    Bruna S. Paulsen, Pankaj Kumar Mandal, Richard L. Frock, Bariş Boyraz, Rachita Yadav, Srigokul Upadhyayula, Paula Gutierrez‐Martinez, Wataru Ebina, Anders L. Fasth, Tomas L. Kirchhausen et al. · 2017 · Nature Biomedical Engineering
  12. NF2/Merlin Inactivation and Potential Therapeutic Targets in Mesothelioma
    Tatsuhiro Sato, Yoshitaka Sekido · 2018 · International Journal of Molecular Sciences
  13. Material solutions for delivery of CRISPR/Cas-based genome editing tools: Current status and future outlook
    Tao Yu Wan, Dong Niu, Chuanbin Wu, Fu‐Jian Xu, George McDonald Church, Ping Yuan · 2019 · Materials Today
  14. A CRISPR-Cas9 delivery system for in vivo screening of genes in the immune system
    Martin W. LaFleur, Thao H. Nguyen, Matthew A. Coxe, Kathleen B. Yates, Justin D. Trombley, Sarah A. Weiss, Flavian D. Brown, Jacob E. Gillis, Daniel J. Coxe, John G. Doench et al. · 2019 · Nature Communications
  15. Membrane protein-regulated networks across human cancers
    Chun‐Yu Lin, Chia‐Hwa Lee, Yi-Hsuan Chuang, Jung-Yu Lee, Yi-Yuan Chiu, Yan‐Hwa Wu Lee, Yuh‐Jyh Jong, Jenn-Kang Hwang, Sing‐Han Huang, Li-Ching Chen et al. · 2019 · Nature Communications
  16. CD47 blockade augmentation of trastuzumab antitumor efficacy dependent on antibody-dependent cellular phagocytosis
    Li-Chung Tsao, Erika J. Crosby, Timothy N. Trotter, Pankaj Agarwal, Bin-Jin Hwang, Chaitanya R. Acharya, Casey W. Shuptrine, Tao Wang, Jun-Ping Wei, Xiao Yi Yang et al. · 2019 · JCI Insight
  17. IL-17R-EGFR axis links wound healing to tumorigenesis in Lrig1+ stem cells
    Chen, Xing, Cai, Gang, Liu, Caini, Zhao, Junjie, Gu, Chunfang, Wu, Ling, Hamilton, Thomas A., Zhang, Cun-jin, Ko, Jennifer, Zhu, Liang et al. · 2019 · Journal of Experimental Medicine
  18. Function genomics of abiotic stress tolerance in plants: a CRISPR approach
    Mukesh Jain · 2015 · Frontiers in Plant Science
  19. Activation of concurrent apoptosis and necroptosis by SMAC mimetics for the treatment of refractory and relapsed ALL
    Scott McComb, Júlia Aguadé-Gorgorió, Lena Behrmann, Blerim Marovca, Gunnar Cario, Cornelia Eckert, Martin Schrappe, Martin Stanulla, Arend von Stackelberg, Jean‐Pierre Bourquin et al. · 2016 · Science Translational Medicine
  20. Affecting HEK293 Cell Growth and Production Performance by Modifying the Expression of Specific Genes
    Laura Abaandou, David N. Quan, Joseph Shiloach · 2021 · Cells
  21. Natural variation in gene expression and viral susceptibility revealed by neural progenitor cell villages
    Wells, Michael F., Nemesh, James, Ghosh, Sulagna, Mitchell, Jana M., Salick, Max R., Mello, Curtis J., Meyer, Daniel, Pietilainen, Olli, Piccioni, Federica, Guss, Ellen J. et al. · 2023 · Cell Stem Cell
  22. Loss‐of‐Function Genetic Screening Identifies Aldolase A as an Essential Driver for Liver Cancer Cell Growth Under Hypoxia
    Niu, Yi, Lin, Ziyou, Wan, Arabella, Sun, Lei, Yan, Shijia, Liang, Heng, Zhan, Siyue, Chen, Dongshi, Bu, Xianzhang, Liu, Peiqing et al. · 2021 · Hepatology
  23. Heat shock proteins in hepatocellular carcinoma: Molecular mechanism and therapeutic potential
    Cun Wang, Yurong Zhang, Kun Guo, Ning Wang, Haojie Jin, Yinkun Liu, Wenxin Qin · 2015 · International Journal of Cancer
  24. Carfilzomib resistance due to ABCB1/MDR1 overexpression is overcome by nelfinavir and lopinavir in multiple myeloma
    Andrej Bešše, Sara Christina Stolze, Leo Rasche, Niels Weinhold, Gareth John Morgan, Marianne Kraus, Jürgen E. Bader, Herman S. Overkleeft, Lenka Bešše, Christoph Driessen · 2017 · Leukemia
  25. CRISPR/Cas9 Genome-Editing System in Human Stem Cells: Current Status and Future Prospects
    Zhao Zhang, Yuelin Zhang, Fei Gao, Shuo Han, Kathryn S.E. Cheah, Hung‐Fat Tse, Qizhou Lian · 2017 · Molecular Therapy — Nucleic Acids
  26. Targeting DNA repair, DNA metabolism and replication stress as anti‐cancer strategies
    Jordi Carreras Puigvert, Kumar Sanjiv, Thomas Helleday · 2015 · FEBS Journal
  27. Germline Gene Editing in Chickens by Efficient CRISPR-Mediated Homologous Recombination in Primordial Germ Cells
    Lazar Dimitrov, Darlene Pedersen, Kathryn H. Ching, Henry Yi, Ellen J. Collarini, Shelley Mettler Izquierdo, Marie‐Cecile van de Lavoir, Philip A. Leighton · 2016 · PLoS ONE
  28. Complementary information derived from CRISPR Cas9 mediated gene deletion and suppression
    Joseph Rosenbluh, Han Xu, William Harrington, Stanley Gill, Xiaoxing Wang, Francisca Vázquez, David E. Root, Aviad Tsherniak, William C. Hahn · 2017 · Nature Communications
  29. Genomic analysis of hairy cell leukemia identifies novel recurrent genetic alterations
    Benjamin Heath Durham, Bartlomiej M. Getta, Sascha Dietrich, Justin Taylor, Helen H. Won, James M. Bogenberger, Sasinya N. Scott, Eun Hee Kim, Young Rock Chung, Stephen S. Chung et al. · 2017 · Blood
  30. Target identification of small molecules using large-scale CRISPR-Cas mutagenesis scanning of essential genes
    Jasper Edgar Neggers, Bert Kwanten, Tim Dierckx, Hiroki Noguchi, Arnout R. D. Voet, Lotte Bral, Kristien Minner, Bob Massant, Nicolas Kint, Michel Delforge et al. · 2018 · Nature Communications
  31. Cancer stem cells and tumorigenesis
    Pingping Zhu, Zusen Fan · 2018 · Biophysics Reports
  32. CRISPR–Cas ribonucleoprotein mediated homology-directed repair for efficient targeted genome editing in microalgae Nannochloropsis oceanica IMET1
    Mihris Ibnu Saleem Naduthodi, Prarthana Mohanraju, Christian Südfeld, Sarah D’Adamo, María J. Barbosa, John van der OOST · 2019 · Biotechnology for Biofuels
  33. Precision cancer mouse models through genome editing with CRISPR-Cas9
    Haiwei Mou, Zachary Kennedy, Daniel G. Anderson, Hao Yin, Wen Xue · 2015 · Genome Medicine
  34. Changes in mRNA abundance drive shuttling of RNA binding proteins, linking cytoplasmic RNA degradation to transcription
    Sarah E. Gilbertson, Joel D. Federspiel, Ella Hartenian, Ileana M. Cristea, Britt A. Glaunsinger · 2018 · eLife
  35. Current and future prospects for CRISPR‐based tools in bacteria
    Michelle L. Luo, Ryan T. Leenay, Chase L. Beisel · 2015 · Biotechnology and Bioengineering
  36. Human MxB Protein Is a Pan-herpesvirus Restriction Factor
    Mirjam Schilling, Lorenzo Bulli, Sebastian Weigang, Laura Graf, Sebastian Naumann, Corinna Patzina, Valentina Wagner, Liane Bauersfeld, Caroline Goujon, Hartmut Hengel et al. · 2018 · Journal of Virology
  37. Bacterial exopolysaccharides: Chemical structures, gene clusters and genetic engineering
    Xiaqing Sun, Jianfa Zhang · 2021 · International Journal of Biological Macromolecules
  38. GRHL2 coordinates regeneration of a polarized mucociliary epithelium from basal stem cells
    Xia Gao, Aman S. Bali, Scott H. Randell, Brigid L.M. Hogan · 2015 · The Journal of Cell Biology
  39. Creating and evaluating accurate CRISPR-Cas9 scalpels for genomic surgery
    Mehmet Fatih Bolukbasi, Ankit Gupta, Scot A. Wolfe · 2015 · Nature Methods
  40. A Biophysical Model of CRISPR/Cas9 Activity for Rational Design of Genome Editing and Gene Regulation
    Iman Farasat, Howard M. Salis · 2016 · PLoS Computational Biology
  41. Newcastle Disease Virus V Protein Degrades Mitochondrial Antiviral Signaling Protein To Inhibit Host Type I Interferon Production via E3 Ubiquitin Ligase RNF5
    Yingjie Sun, Hang Zheng, Shengqing Yu, Yunlei Ding, Wei Wu, Xuming Mao, Ying Liao, Chunchun Meng, Zaib Ur Rehman, Lei Tan et al. · 2019 · Journal of Virology
  42. Rational targeting of a NuRD subcomplex guided by comprehensive in situ mutagenesis
    Falak Sher, Mir Ahamed Hossain, Davide Seruggia, Vivien A. C. Schoonenberg, Qiuming Yao, Paolo Cifani, Laura M. K. Dassama, Mitchel A. Cole, Chunyan Ren, Divya S. Vinjamur et al. · 2019 · Nature Genetics
  43. A systems approach to infectious disease
    Manon Eckhardt, Judd F. Hultquist, Robyn M. Kaake, Ruth Hüttenhain, Nevan J. Krogan · 2020 · Nature Reviews Genetics
  44. Neutrophil swarming delays the growth of clusters of pathogenic fungi
    Alex R. Hopke, Allison K. Scherer, Samantha Kreuzburg, Michael S. Abers, Christa S. Zerbe, Mary C. Dinauer, Michael K. Mansour, Daniel Irimia · 2020 · Nature Communications
  45. Programmable Extracellular Vesicles for Macromolecule Delivery and Genome Modifications
    Xiaojuan Zhang, Quanbin Xu, Zhike Zi, Zeyu Liu, Chun Wan, Lauren Crisman, Jingshi Shen, Xuedong Liu · 2020 · Developmental Cell
  46. Proteomic Screens for Suppressors of Anoikis Identify IL1RAP as a Promising Surface Target in Ewing Sarcoma
    Haifeng Zhang, Christopher S. Hughes, Wei Li, Jianzhong He, Didier Surdez, Amal M. El-Naggar, Hongwei Cheng, Anna Prudova, Alberto Delaidelli, Gian Luca Negri et al. · 2021 · Cancer Discovery
  47. A human apolipoprotein L with detergent-like activity kills intracellular pathogens
    Ryan G. Gaudet, Shiwei Zhu, Anushka Halder, Bae-Hoon Kim, Clinton J. Bradfield, Shuai Huang, Dijin Xu, Agnieszka Mamińska, Thanh Ngoc Nguyen, Michael Lazarou et al. · 2021 · Science
  48. Using traditional machine learning and deep learning methods for on- and off-target prediction in CRISPR/Cas9: a review
    Zeinab Sherkatghanad, Moloud Abdar, Jérémy Charlier, Vladimir Makarenkov · 2023 · Briefings in Bioinformatics
  49. NCG 5.0: updates of a manually curated repository of cancer genes and associated properties from cancer mutational screenings
    Ömer An, Giovanni Marco Dall’Olio, Thanos P. Mourikis, Francesca D. Ciccarelli · 2015 · Nucleic Acids Research
  50. Genome Editing in Human Pluripotent Stem Cells: Approaches, Pitfalls, and Solutions
    Hendriks, William T., Warren, Curtis R., Cowan, Chad A. · 2016 · Cell Stem Cell
  51. CRISPR guide RNA design for research applications
    Stephanie Elizabeth Mohr, Yanhui Hu, Ben Ewen‐Campen, Benjamin E. Housden, Raghuvir Viswanatha, Norbert Perrimon · 2016 · FEBS Journal
  52. Editing the genome of hiPSC with CRISPR/Cas9: disease models
    Andrew Roger Bassett · 2017 · Mammalian Genome
  53. Myc and Dnmt1 impede the pluripotent to totipotent state transition in embryonic stem cells
    Xudong Fu, Xiaoji Wu, Mohamed Nadhir Djekidel, Yi Zhang · 2019 · Nature Cell Biology
  54. A global lipid map defines a network essential for Zika virus replication
    Hans C. Leier, Jules B. Weinstein, Jennifer E Kyle, Joon‐Yong Lee, Lisa Bramer, Kelly G. Stratton, Douglas Kempthorne, Aaron R. Navratil, Endale G. Tafesse, Thorsten Hornemann et al. · 2020 · Nature Communications
  55. A Scalable Genome-Editing-Based Approach for Mapping Multiprotein Complexes in Human Cells
    Mathieu Dalvai, Jérémy Loehr, Karine Jacquet, Caroline Huard, Céline Lopez‐Roques, Pauline M. Herst, Jacques Côté, Yannick Doyon · 2015 · Cell Reports
  56. Non-viral delivery of genome-editing nucleases for gene therapy
    M Wang, Zachary Glass, Qiaobing Xu · 2016 · Gene Therapy
  57. In vivo loss-of-function screens identify KPNB1 as a new druggable oncogene in epithelial ovarian cancer
    Michiko Kodama, Takahiro Kodama, Justin Y. Newberg, Hiroyuki Katayama, Makoto Kobayashi, Samir Hanash, Kosuke Yoshihara, Zhubo Wei, Jean Ching-Yi Tien, Roberto Rangel et al. · 2017 · Proceedings of the National Academy of Sciences
  58. Role of angiopoietin-like 3 (ANGPTL3) in regulating plasma level of low-density lipoprotein cholesterol
    Yuxin Xu, Valeska Redon, Haojie Yu, William Querbes, James P. Pirruccello, Abigail Liebow, Amy Deik, Kevin Trindade, Xiao Wang, Kiran Musunuru et al. · 2017 · Atherosclerosis
  59. Systematic Dissection of the Metabolic-Apoptotic Interface in AML Reveals Heme Biosynthesis to Be a Regulator of Drug Sensitivity
    Kevin Lin, Abigail Xie, Justine C. Rutter, Yeong-ran Ahn, Julia M. Lloyd-Cowden, Amanda Nichols, Ryan S. Soderquist, Timothy R. Koves, Deborah M. Muoio, Nancie J. MacIver et al. · 2019 · Cell Metabolism
  60. A consensus set of genetic vulnerabilities to ATR inhibition
    Nicole Hustedt, Alejandro Álvarez-Quilón, Andrea McEwan, Jing Yi Yuan, Tiffany Cho, Lisa Koob, Traver Hart, Daniel Durocher · 2019 · Open Biology
  61. A glance at genome editing with CRISPR–Cas9 technology
    Antara Barman, Bornali Deb, Supriyo Chakraborty · 2019 · Current Genetics
  62. Targeting Cdk11 in osteosarcoma cells using the CRISPR‐cas9 system
    Yong Feng, Slim O. Sassi, Jacson K. Shen, Xiaoqian Yang, Yan Gao, Eiji Osaka, Jianming Zhang, Shuhua Yang, Yang Cao, Henry J. Mankin et al. · 2014 · Journal of Orthopaedic Research®
  63. MC1R signaling. Intracellular partners and pathophysiological implications
    Cecilia Herráiz, José Carlos García-Borrón, Celia Jiménez‐Cervantes, Concepción Olivares · 2017 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  64. CRISPR/Cas9 library screening for drug target discovery
    Morito Kurata, Kouhei Yamamoto, Branden S. Moriarity, Masanobu Kitagawa, David A. Largaespada · 2017 · Journal of Human Genetics
  65. ATP13A2 facilitates HDAC6 recruitment to lysosome to promote autophagosome–lysosome fusion
    Ruoxi Wang, Jieqiong Tan, Tingting Chen, Hailong Han, Runyi Tian, Ya Tan, Yiming Wu, Jingyi Cui, Fang Chen, Jie Li et al. · 2018 · The Journal of Cell Biology
  66. Targeting the interaction between RNA-binding protein HuR and FOXQ1 suppresses breast cancer invasion and metastasis
    Xiaoqing Wu, Gulhumay Gardashova, Lan Lan, Shuang Han, Cuncong Zhong, Rebecca T. Marquez, Lanjing Wei, Spencer Wood, Sudeshna Roy, Ragul Gowthaman et al. · 2020 · Communications Biology
  67. Profiling the genetic determinants of chromatin accessibility with scalable single-cell CRISPR screens
    Liscovitch-Brauer, Noa, Montalbano, Antonino, Deng, Jiale, Méndez-Mancilla, Alejandro, Wessels, Hans-Hermann, Moss, Nicholas G., Kung, Chia-Yu, Sookdeo, Akash, Guo, Xinyi, Geller, Evan et al. · 2021 · Nature Biotechnology
  68. CRISPR-based technologies: prokaryotic defense weapons repurposed
    Rebecca M. Terns, Michael P. Terns · 2014 · Trends in Genetics
  69. ER Stress Signaling Promotes the Survival of Cancer “Persister Cells” Tolerant to EGFR Tyrosine Kinase Inhibitors
    Hideki Terai, Shunsuke Kitajima, Danielle S. Potter, Yusuke Matsui, Laura Gutierrez Quiceno, Ting Chen, Tae Jung Kim, Maria Rusan, Tran Cam Thai, Federica Piccioni et al. · 2017 · Cancer Research
  70. Cyclosporine H Overcomes Innate Immune Restrictions to Improve Lentiviral Transduction and Gene Editing In Human Hematopoietic Stem Cells
    C. Petrillo, Lucy G. Thorne, G. Unali, Giulia Schiroli, A. Giordano, F. Piras, I. Cuccovillo, Sarah J. Petit, Fatima Ahsan, M. Noursadeghi et al. · 2018 · Cell Stem Cell
  71. PRMT1 loss sensitizes cells to PRMT5 inhibition
    Guozhen Gao, Liang Zhang, Oscar David Villarreal, Wei He, Dan Su, Ella Bedford, Phoebe Moh, Jianjun Shen, Xiaobing Shi, Mark T. Bedford et al. · 2019 · Nucleic Acids Research
  72. Loss of heterozygosity of essential genes represents a widespread class of potential cancer vulnerabilities
    Caitlin A. Nichols, William J. Gibson, Meredith S. Brown, Jack A. Kosmicki, John P. Busanovich, Hope Y. Wei, Laura M. Urbanski, Naomi Currimjee, Ashton C. Berger, Galen F. Gao et al. · 2020 · Nature Communications
  73. Low-Dose Vertical Inhibition of the RAF-MEK-ERK Cascade Causes Apoptotic Death of KRAS Mutant Cancers
    Irem Ozkan‐Dagliyan, J. Nathaniel Diehl, Samuel D. George, Antje Schaefer, Bjoern Papke, Kathleen Klotz‐Noack, Andrew M. Waters, Craig M. Goodwin, Prson Gautam, Mariaelena Pierobon et al. · 2020 · Cell Reports
  74. CRISPR-based therapeutics: current challenges and future applications
    Ashley E. Modell, Donghyun Lim, Tuan M. Nguyen, Vedagopuram Sreekanth, Amit Choudhary · 2021 · Trends in Pharmacological Sciences
  75. Autophagy protects intestinal epithelial Cells against Deoxynivalenol toxicity by alleviating oxidative stress via IKK signaling pathway
    Yulong Tang, Jianjun Li, Fengna Li, Chien‐An Andy Hu, Peng Liao, Kunrong Tan, Bie Tan, Xia Xiong, Gang Liu, Tiejun Li et al. · 2015 · Free Radical Biology and Medicine
  76. Key roles of necroptotic factors in promoting tumor growth
    Xinjian Liu, Min Zhou, Ling Mei, Jiaying Ruan, Qian Hu, Jing Peng, Hang Su, Hong Liao, Shanling Liu, Weiping Liu et al. · 2016 · Oncotarget
  77. Shigella flexneri suppresses NF-κB activation by inhibiting linear ubiquitin chain ligation
    Maarten F. de Jong, Zixu Liu, Didi Chen, Neal M. Alto · 2016 · Nature Microbiology
  78. Inhibition of histone deacetylase reduces transcription of NADPH oxidases and ROS production and ameliorates pulmonary arterial hypertension
    Feng Chen, Xueyi Li, Emily Aquadro, Stephen B. Haigh, Jiliang Zhou, David W. Stepp, Neal L. Weintraub, Scott A. Barman, David J. Fulton · 2016 · Free Radical Biology and Medicine
  79. Variant-aware saturating mutagenesis using multiple Cas9 nucleases identifies regulatory elements at trait-associated loci
    Matthew C. Canver, Samuel Lessard, Luca Pinello, Yuxuan Wu, Yann Ilboudo, Emily N Stern, Austen J Needleman, F. Galactéros, Carlo Brugnara, Abdullah Kutlar et al. · 2017 · Nature Genetics
  80. Deletion of the Bombyx mori odorant receptor co-receptor (BmOrco) impairs olfactory sensitivity in silkworms
    Qun Liu, Wei Liu, Baosheng Zeng, Guirong Wang, Dejun Hao, Yongping Huang · 2017 · Insect Biochemistry and Molecular Biology
  81. High-Throughput Imaging for the Discovery of Cellular Mechanisms of Disease
    Gianluca Pegoraro, Tom Misteli · 2017 · Trends in Genetics
  82. Mapping a functional cancer genome atlas of tumor suppressors in mouse liver using AAV-CRISPR–mediated direct in vivo screening
    Guangchuan Wang, Ryan Dz-Wei Chow, Lupeng Ye, Christopher D. Guzman, Xiaoyun Dai, Matthew B. Dong, Feng Zhang, Phillip A. Sharp, Randall J. Platt, Sidi Chen · 2018 · Science Advances
  83. STAT3 associates with vacuolar H+-ATPase and regulates cytosolic and lysosomal pH
    Bin Liu, Johan Palmfeldt, Lin Lin, Alexandria Colaço, Knut Kristoffer Bundgaard Clemmensen, Jinrong Huang, Fengping Xu, Xin Liu, Kenji Maeda, Yonglun Luo et al. · 2018 · Cell Research
  84. Synthetic Lethality of Wnt Pathway Activation and Asparaginase in Drug-Resistant Acute Leukemias
    Laura Hinze, Maren Pfirrmann, Salmaan Karim, James Degar, Connor McGuckin, Divya S. Vinjamur, Joshua R. Sacher, Kristen E. Stevenson, Donna S Neuberg, Esteban A. Orellana et al. · 2019 · Cancer Cell
  85. Human iPSC-derived neuronal model of Tau-A152T frontotemporal dementia reveals tau-mediated mechanisms of neuronal vulnerability
    Silva, M. Catarina, Cheng, Chialin, Mair, Waltraud, Almeida, Sandra, Fong, Helen, Biswas, M. Helal U., Zhang, Zhijun, Huang, Yadong, Temple, Sally, Coppola, Giovanni et al. · 2016 · Stem Cell Reports
  86. Modeling Disease In Vivo With CRISPR/Cas9
    Lukas E. Dow · 2015 · Trends in Molecular Medicine
  87. Resources for the design of CRISPR gene editing experiments
    Daniel B. Graham, David E. Root · 2015 · Genome biology
  88. TGF-β-induced stromal CYR61 promotes resistance to gemcitabine in pancreatic ductal adenocarcinoma through downregulation of the nucleoside transporters hENT1 and hCNT3
    Rachel Hesler, Jennifer Jing Huang, Mark D. Starr, Victoria M. Treboschi, Alyssa Bernanke, Andrew B. Nixon, Shannon J. McCall, Rebekah Ruth White, Gerard C. Blobe · 2016 · Carcinogenesis
  89. Systematic identification of regulatory variants associated with cancer risk
    Song Liu, Yuwen Liu, Qin Zhang, Jiayu Wu, Junbo Liang, Shan Yu, Gong‐Hong Wei, Kevin P. White, Xiaoyue Wang · 2017 · Genome biology
  90. Friend or Foe? Evidence Indicates Endogenous Exosomes Can Deliver Functional gRNA and Cas9 Protein
    Ran Chen, Hongxin Huang, Hui Liu, Jingyuan Xi, Jing Ning, Wanjia Zeng, Congle Shen, Ting Zhang, Guangxin Yu, Qiang Xu et al. · 2019 · Small
  91. CRISPR technologies for stem cell engineering and regenerative medicine
    Mu‐Nung Hsu, Yu‐Han Chang, Vu Anh Truong, Po‐Liang Lai, Thị Kieu Nuong Nguyen, Yu‐Chen Hu · 2019 · Biotechnology Advances
  92. The chromatin remodeler ALC1 underlies resistance to PARP inhibitor treatment
    Szilvia Juhász, Rebecca Smith, Tamás Schauer, Dóra Spekhardt, Hasan Mamar, Siham Zentout, Catherine Chapuis, Sébastien Huet, Gyula Timinszky · 2020 · Science Advances
  93. Confined migration promotes cancer metastasis through resistance to anoikis and increased invasiveness
    Deborah Fanfone, Zhichong Wu, Jade Mammi, Kévin Berthenet, David Neves, Kathrin Weber, Andrea Halaburkova, François Virard, Félix Bunel, Catherine Jamard et al. · 2022 · eLife
  94. Genetic expression in cancer research: Challenges and complexity
    Hengrui Liu, Zheng Guo, Panpan Wang · 2024 · Gene Reports
  95. Enabling functional genomics with genome engineering
    Isaac B. Hilton, Charles A. Gersbach · 2015 · Genome Research
  96. JACKS: joint analysis of CRISPR/Cas9 knockout screens
    Felicity R. Allen, Fiona M. Behan, Anton Khodak, Francesco Iorio, Kosuke Yusa, Mathew J. Garnett, Leopold Parts · 2019 · Genome Research
  97. CRISPR/Cas9 for Human Genome Engineering and Disease Research
    Xin Xiong, Meng Chen, Wendell A. Lim, Dehua Zhao, Lei S. Qi · 2016 · Annual Review of Genomics and Human Genetics
  98. Emerging roles for long noncoding RNAs in skeletal biology and disease
    Nguyen P.T. Huynh, Britta A. Anderson, Farshid Guilak, Audrey McAlinden · 2016 · Connective Tissue Research
  99. Different Effects of sgRNA Length on CRISPR-mediated Gene Knockout Efficiency
    Jianping Zhang, Xiaolan Li, Amanda Neises, Wanqiu Chen, Linping Hu, Guangzhen Ji, Jun-Yao Yu, Jing Xu, Weiping Yuan, Tao Cheng et al. · 2016 · Scientific Reports
  100. CRISPR/Cas9 system targeting regulatory genes of HIV-1 inhibits viral replication in infected T-cell cultures
    Youdiil Ophinni, Mari Inoue, Tomohiro Kotaki, Masanori Kameoka · 2018 · Scientific Reports